stoxline Quote Chart Rank Option Currency Glossary
  
Accolade, Inc. (ACCD)
6.51  0.08 (1.24%)    06-12 16:00
Open: 6.61
High: 6.75
Volume: 783,866
  
Pre. Close: 6.43
Low: 6.445
Market Cap: 510(M)
Technical analysis
2024-06-12 4:20:07 PM
Short term     
Mid term     
Targets 6-month :  8.63 1-year :  9.4
Resists First :  7.39 Second :  8.05
Pivot price 6.95
Supports First :  6.32 Second :  5.26
MAs MA(5) :  6.64 MA(20) :  7.07
MA(100) :  9.4 MA(250) :  10.45
MACD MACD :  -0.4 Signal :  -0.4
%K %D K(14,3) :  13.9 D(3) :  17.6
RSI RSI(14): 35.8
52-week High :  15.35 Low :  6.32
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ ACCD ] has closed above bottom band by 17.5%. Bollinger Bands are 42.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 18 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 6.76 - 6.79 6.79 - 6.82
Low: 6.37 - 6.41 6.41 - 6.44
Close: 6.45 - 6.51 6.51 - 6.56
Company Description

Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. It also provides second opinion consultation and health care decision support services. The company serves employers who provide their employees and their employees' families a single place to turn for their health, healthcare, and benefits needs. Accolade, Inc. was incorporated in 2007 and is headquartered in Plymouth Meeting, Pennsylvania.

Headline News

Wed, 12 Jun 2024
Accolade to Announce Fiscal First Quarter 2025 Financial Results - Yahoo Finance Australia

Tue, 11 Jun 2024
Accolade (NASDAQ:ACCD) Trading Down 4.6% - MarketBeat

Fri, 07 Jun 2024
Parallel Advisors LLC Has $67000 Stock Position in Accolade, Inc. (NASDAQ:ACCD) - Defense World

Wed, 05 Jun 2024
Does Accolade (NASDAQ:ACCD) Have A Healthy Balance Sheet? - Simply Wall St

Tue, 04 Jun 2024
Accolade, Inc. (NASDAQ:ACCD) Shares Acquired by PNC Financial Services Group Inc. - Defense World

Wed, 29 May 2024
Accolade To Present at William Blair Growth Stock Conference - GlobeNewswire

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Neutral
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Outperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Underperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Neutral
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Neutral
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Outperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Medical - Healthcare Information Services
Shares Out 78 (M)
Shares Float 71 (M)
Held by Insiders 2.9 (%)
Held by Institutions 88.8 (%)
Shares Short 3,440 (K)
Shares Short P.Month 3,140 (K)
Stock Financials
EPS -1.34
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 5.71
Profit Margin -24.1 %
Operating Margin -6.4 %
Return on Assets (ttm) -8.4 %
Return on Equity (ttm) -21.8 %
Qtrly Rev. Growth 26.1 %
Gross Profit (p.s.) 0
Sales Per Share 5.28
EBITDA (p.s.) -0.91
Qtrly Earnings Growth 0 %
Operating Cash Flow -16 (M)
Levered Free Cash Flow 12 (M)
Stock Valuations
PE Ratio -4.9
PEG Ratio 6.1
Price to Book value 1.14
Price to Sales 1.23
Price to Cash Flow -31.55
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android